DHA-rich algal oil (infant and follow on formula). EC No.156

September 2013 : Application from DSM Nutritional Products for the authorisation of DHA-rich algal oil from microalgae Schizochytrium sp, under the Novel Food Regulation (EC) 258/97. Under evaluation.

This is the sixth full application made for oils rich in polyunsaturated fatty acids obtained from the microalgae Schizochytrium sp. This oil, which is rich in the fatty acid docosahexaenoic acid (DHA) is obtained from another strain of the species and differs from previous applications in that it is proposed for use, primarily, in infant and follow on formula. DHA that is currently used in infant formula is typically obtained from fish (tuna) oil or using a DHA rich oil from Crypthecodinium cohnii.

Before any new food product can be introduced on the European market, it must be rigorously assessed for safety. In the UK, the assessment of novel foods is carried out by an independent committee of scientists appointed by the Food Standards Agency, the Advisory Committee on Novel Foods and Processes (ACNFP)

The ACNFP has considered this application and have formulated a positive draft opinion. Any comments on this draft opinion should be sent to ACNFP Secretariat by 28 February 2014 and will be passed to the Committee during its assessment of this novel food ingredient.

All views/comments received by the Agency will be made available for public examination. If you would prefer your comments NOT to be made publicly available, please indicate this by fully completing and returning the data protection form (attached below) together with your response.